临床儿科杂志 ›› 2018, Vol. 36 ›› Issue (10): 796-.doi: 10.3969/j.issn.1000-3606.2018.10.017

• 文献综述 • 上一篇    下一篇

川崎病并发巨噬细胞活化综合征的研究进展#br#

周利兵综述, 吕海涛审校   

  1. 苏州大学附属儿童医院(江苏苏州 215000)
  • 收稿日期:2018-10-15 出版日期:2018-10-15 发布日期:2018-10-15
  • 基金资助:
    国家自然科学基金面上项目(No.81570455)

Research progress in Kawasaki disease complicated with macrophage activation syndrome

 Reviewer: ZHOU Libing, Reviser: LYU Haitao   

  1. Children’s Hospital of Soochow University, Suzhou 215000, Jiangsu, China
  • Received:2018-10-15 Online:2018-10-15 Published:2018-10-15

摘要:  巨噬细胞活化综合征是川崎病一种罕见的并发症,因其有起病隐匿、进展快、影响全身多器官系统、致死率 高等特点,需要给予更多的重视。由于目前国际上暂无统一的川崎病合并巨噬细胞活化综合征的诊断标准和治疗方案,因 此常被漏诊或误诊。文章就川崎病并发巨噬细胞活化综合征的流行病学、免疫学机制、诊断和治疗等研究进展进行综述。

Abstract: Macrophage activation syndrome (MAS) is a rare complication of Kawasaki disease and more attention is needed for it in clinic because of its insidious onset, rapid progression, multiple organ system involvement and high mortality. There is no international unified diagnostic criteria and treatment regimen for Kawasaki disease complicated with macrophage activation syndrome at present, so it is often missed or misdiagnosed. This article reviews the epidemiology, immunological mechanism, diagnosis and treatment of Kawasaki disease complicated with macrophage activation syndrome.